Evaluation of Thymus vulgaris aqueous extract as a natural antimicrobial agent against urinary tract infection pathogens

Résumé

Introduction. Urinary tract infections (UTIs) are often caused by bacteria such as Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) which can lead to major health problems. The purpose of this study was to to examine the antibacterial effects of extract of Thymus vulgaris aqueous against these uropathogens. 

Materials and Methods. The aqueous extract of Thymus vulgaris was prepared via hot water decoction (yield: 3.6 g from 30 g dried plant material 12%). Bacterial strains were isolated from 25 clinical urine samples and identified using selective culture media using the Gram staining and biochemical characterization. Antibacterial activity was assessed by using the agar well diffusion method with extract concentrations (50, 100 and 200 mg/mL) of Thymus vulgaris extract. 

Results. The results of this study showed dose dependent of inhibition zone with S. aureus showing greater susceptibility (ZOI: 10–27 mm) compared to E. coli (ZOI: 9–23 mm). Ciprofloxacin shown larger inhibition zone (28–30 mm). 

Conclusions. These findings demonstrate promising antibacterial potential of T. vulgaris aqueous extract as a natural alternative to combat antibiotic-resistant UTIs. These results support previous investigation about T. vulgaris as an alternative or complementary treatment for bacterial infections.

https://doi.org/10.38045/ohrm.2026.1.02
pdf (English)

|Vues: 675| |pdf (English) Téléchargements: 401|


pdf (English)
Creative Commons License

Ce travail est disponible sous la licence Creative Commons Attribution 4.0 International .

Copyright (c) 2025 Hashim Abass, Muthanna Al-Mahdawi, Mohammed Challoob, Hayder Abed

##plugins.generic.usageStats.downloads##

##plugins.generic.usageStats.noStats##

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370